Skip to main content
Top
Published in: Breast Cancer 1/2012

01-01-2012 | Special Ariticle

Trends in local therapy application for early breast cancer patients in the Japanese Breast Cancer Society Breast Cancer Registry during 2004–2009

Authors: Shigehira Saji, Masahiro Hiraoka, Yutaka Tokuda, Naohito Fukui, Tadashi Ikeda

Published in: Breast Cancer | Issue 1/2012

Login to get access

Excerpt

The Japanese Breast Cancer Society (JBCS) has been accumulating breast cancer patient data since 1975, reaching a total of 188,265 cases over 29 years. However, the recent increase of breast cancer incidence in Japan made it impossible for us to maintain the same data pool system for further analysis of trends in the disease. Therefore, the JBCS launched a new patient registration system in 2004, including 147,192 cases during the period 2004–2009. …
Literature
1.
go back to reference Sonoo H, Noguchi S, Academic Committee of the Japanese Breast Cancer Society. Results of questionnaire survey on breast cancer surgery in Japan 2004–2006. Breast Cancer. 2008;15(1):3–4.PubMedCrossRef Sonoo H, Noguchi S, Academic Committee of the Japanese Breast Cancer Society. Results of questionnaire survey on breast cancer surgery in Japan 2004–2006. Breast Cancer. 2008;15(1):3–4.PubMedCrossRef
2.
go back to reference Giuliano AE, Hunt KK, Ballman KV, Beitsch PD, Whiworth PW, Blumencranz PW, Leitch AM, Saha S, McCall LM, Morrow M. Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. JAMA. 2011;305(6):569–75.PubMedCrossRef Giuliano AE, Hunt KK, Ballman KV, Beitsch PD, Whiworth PW, Blumencranz PW, Leitch AM, Saha S, McCall LM, Morrow M. Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. JAMA. 2011;305(6):569–75.PubMedCrossRef
Metadata
Title
Trends in local therapy application for early breast cancer patients in the Japanese Breast Cancer Society Breast Cancer Registry during 2004–2009
Authors
Shigehira Saji
Masahiro Hiraoka
Yutaka Tokuda
Naohito Fukui
Tadashi Ikeda
Publication date
01-01-2012
Publisher
Springer Japan
Published in
Breast Cancer / Issue 1/2012
Print ISSN: 1340-6868
Electronic ISSN: 1880-4233
DOI
https://doi.org/10.1007/s12282-011-0308-z

Other articles of this Issue 1/2012

Breast Cancer 1/2012 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine